Epidemiology and Clinical Characteristics of Fatty Pancreas Disease in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Systematic Review.

Key Points

• The research examines the relationship between fatty pancreas disease and metabolic dysfunction-associated steatotic liver disease.
• Systematic review of existing literature
• Assessment of epidemiological data on fatty pancreas disease
• Analysis of cardiometabolic characteristics in patients with MASLD and FPD.
• Approximately 50% of patients with MASLD have concomitant fatty pancreas disease (FPD).
• FPD is associated with an adverse cardiometabolic phenotype.
• Evidence suggests a need for integrated approaches to understand the implications of multiorgan ectopic fat.